Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
585
currently held
Exits tracked
189
hand-checked
Sectors covered
1
across the portfolio
Countries covered
30
from every market
740 companies matching · Page 7 of 15
Concert Bio
Nucleus Capital I
United KingdomSector
Biotech
InvestorNucleus Capital
Entry
2022
Hold
4yr
Concinnity Genetics
Old College Capital LP
UKSector
Biotech
InvestorOld College Capital
Entry
2024
Hold
2yr
Confo Therapeutics
Wellington Partners Life Sciences
BelgiumSector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Congruence Therapeutics
Angelini Ventures
Canada
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
Connecta Therapeutics
Inveready Biotech III
SpainSector
Biotech
InvestorInveready Asset Management
Entry
2022
Hold
4yr
ConstructiveBio
Amadeus V Technology Fund
UKSector
Biotech
InvestorAmadeus Capital Partners
Entry
2022
Hold
4yr
Corat Therapeutics GmbH
NBank Capital Beteiligungsfonds
GermanySector
Biotech
InvestorNBank Capital
Entry
2020
Hold
6yr
Core Biogenesis
Digital 3
FranceSector
Biotech
InvestorXAnge
Entry
2020
Hold
6yr
Corion Biotech
LIFTT
ItalySector
Biotech
InvestorLIFTT
Entry
2020
Hold
6yr
CoSyne Therapeutics
Backed Fund II
UKSector
Biotech
InvestorBACKED VC
Entry
2022
Hold
4yr
Creasallis
BlueYard Capital Fund III
United KingdomSector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Crucible Therapeutics
Northern Gritstone Evergreen
UKSector
Biotech
InvestorNorthern Gritstone
Entry
2023
Hold
3yr
CrystalsFirst GmbH
Technologiefonds Hessen
GermanySector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
Cumulus Oncology
Scottish National Investment Bank (Balance Sheet)
UKSector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Curve Therapeutics
Columbus Life Sciences Fund IV
United KingdomSector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
cutanos
HTGF III
AustriaSector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
CV6 Therapeutics (NI) Ltd
QUBIS Ltd
UKSector
Biotech
InvestorQubis
Entry
2019
Hold
7yr
Cyclarity Therapeutics
KIZOO Evergreen (Balance Sheet)
United StatesSector
Biotech
InvestorKIZOO Technology Capital
Entry
2019
Hold
7yr
Cytoki Pharma
Ysios BioFund III
DK
Sector
Biotech
InvestorYsios Capital Partners
Entry
2021
Hold
5yr
Damona Pharmaceuticals
Angelini Ventures
Canada
Sector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
Dilafor
Rosetta Capital IV
SwedenSector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
DNTOX
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Draig Therapeutics
SV7 Impact Medicine Fund
UKSector
Biotech
InvestorSV Health Managers
Entry
2025
Hold
1yr
Draupnir Bio
HTGF III
DenmarkSector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2018
Hold
8yr
DunAD Therapeutics
Wellington Partners Life Sciences
United KingdomSector
Biotech
InvestorWellington Partners
Entry
2021
Hold
5yr
Dynamic42
Thueringer Startup-Fonds (TSF)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2020
Hold
6yr
Dynamic42 GmbH
Thueringer Startup-Fonds (TSF)
GermanySector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2019
Hold
7yr
Elastrin Therapeutics
KIZOO Evergreen (Balance Sheet)
United StatesSector
Biotech
InvestorKIZOO Technology Capital
Entry
2021
Hold
5yr
Engrail Therapeutics
Ysios BioFund III
USSector
Biotech
InvestorYsios Capital Partners
Entry
2024
Hold
2yr
EnsiliTech
Elbow Beach Capital
UKSector
Biotech
InvestorElbow Beach Investments
Entry
2023
Hold
3yr
EnteroBiotix
Scottish National Investment Bank (Balance Sheet)
UKSector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Enterprise Therapeutics
Panakes Fund Purple
United KingdomSector
Biotech
InvestorPanakes Partners SGR
Entry
2024
Hold
2yr
Enthera
Atlante Seed
ItalySector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2020
Hold
6yr
EpiBone
EMV Capital Evergreen Fund
United StatesSector
Biotech
InvestorEMV Capital
Entry
2020
Hold
6yr
Epigenomics AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
GermanySector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2018
Hold
8yr
Epitopea
CIC Fund II
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2022
Hold
4yr
Epsilogen
ALSA Ventures European Biotechnology Fund
UKSector
Biotech
InvestorALSA Ventures
Entry
2018
Hold
8yr
Eternygen
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2012
Hold
14yr
Etheros
Backed Fund III
UKSector
Biotech
InvestorBACKED VC
Entry
2023
Hold
3yr
Evox Therapeutics
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
10yr
Extend
Angelini Ventures
ItalySector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
FabricNano
Backed Fund II
UKSector
Biotech
InvestorBACKED VC
Entry
2019
Hold
7yr
FibroFind
Vespa Capital III
UKSector
Biotech
InvestorVespa Capital
Entry
2025
Hold
1yr
Focal Biosciences
Apollo Health Ventures Fund II
SwitzerlandSector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
Formycon
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2022
Hold
4yr
Freya Therapeutics
Angelini Ventures
DenmarkSector
Biotech
InvestorAngelini Ventures
Entry
2023
Hold
3yr
Gandeeva Therapeutics
Leaps by Bayer
Canada
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Gemma Biotherapeutics
Earlybird Health
United StatesSector
Biotech
InvestorEarlybird Venture Capital
Entry
2024
Hold
2yr
Genbioma
Start Up Capital Navarra
SpainSector
Biotech
InvestorSodena
Entry
2019
Hold
7yr
Gesynta Pharma
XGEN Venture Life Sciences Fund
SwedenSector
Biotech
InvestorXGen Venture SGR
Entry
2025
Hold
1yr